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ABSTRACT  
Background and Purpose: Clinical and radiological findings of intracranial abscesses may mimic the findings of 
brain tumours and vice versa. However, the discrimination is of great clinical importance in planning treatment and in 
following prognosis and response to therapy. This study evaluates the Computed Tomography (CT) perfusion 
parameters, especially the permeability index, with the aim of evaluating the usefulness of dynamic CT perfusion 
imaging as an alternative tool to differentiate necrotic brain tumours and intracerebral abscesses. 
Materials and Methods: A total of 21 patients underwent perfusion CT study and were divided into 2 groups: 
Group 1, patients with necrotic brain tumours (n=13); and Group 2, patients with cerebral abscesses (n=8). The mean 
perfusion parameters were obtained from the enhancing part of the lesion. The relative ratios were then calculated by 
using the results from mirrored regions within the contralateral hemisphere as reference.  
Results: The results of this study showed that there was significant difference in the relative permeability surface 
values between necrotic brain tumours and cerebral abscesses (p=0.005). By applying the ROC curve, a value of 25.1 for 
rPS was found to be the best estimate to distinguish necrotic brain tumours from cerebral abscesses with a specificity of 
88 % and sensitivity of 70 %.  
Conclusion: CT perfusion, especially permeability surface, may allow for better differentiation of cerebral 
abscesses from brain tumours, making it a strong additional imaging modality in the early diagnosis of these two entities. 
© 2009 Biomedical Imaging and Intervention Journal. All rights reserved. 
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INTRODUCTION 
It has been written that tumour angiogenesis differs 
from the infective process in both histological, 
biochemical markers and perfusion study. Tumour 
angiogenesis is characterised morphologically by an 
increase in the number of blood vessels, including new 
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capillaries, capillary sprouts, non-endothelialised 
capillaries, and arterio-venous shunts. Some of these 
abnormal vessels tend to be leaky, which allows large 
molecules such as plasma protein to enter the stroma to 
form the matrix for new vessels.  
Intracranial infection and abscess formation is a 
progressive and dynamic process with its own vascular 
changes. Until recently, options for cerebral perfusion 
measurements were restricted to positron emission 
tomography (PET), single photon emission computed 
tomography (SPECT) or xenon CT. New sequences and 
advances in Magnetic Resonance Imaging (MRI) such as 
MR perfusion, in addition to MR spectroscopy, 
diffusion-weighted echo planar sequences (DWI) and 
apparent diffusion coefficient map (ADC map) have 
helped to differentiate intracranial abscesses and brain 
tumours. However, the application of MRI is sometimes 
limited by its availability, expense, post surgical artifacts 
and the 15-20% patients who are unable to undergo or 
tolerate an MR in acute setting. The introduction of 
dynamic CT perfusion capable of measuring brain 
haemodynamics with short acquisition time, using 
multislice CT available in most radiology departments, 
has been well-received. We conducted a CT perfusion 
study with emphasis on permeability surface area-
product to ascertain its possible role in differentiation of 
cerebral infection and brain tumours. We believe that the 
findings of this study will have valuable clinical 
implications on patient management. 
Permeability surface area-product (PS) measures the 
permeability of the blood brain barrier to contrast 
material. Permeability is related to the diffusion 
coefficient of the contrast agent in the assumed water-
filled capillary endothelieum. It is expressed in the 
equation: PS = -CBF.ln(1-E), where E is the extraction 
fraction, that is the fraction of contrast material that leaks 
into the extravascular space from the intravascular space 
[1].The unit for PS is ml/100gm/min.  
METHODOLOGY 
This was a cross-sectional study of 25 patients with 
a single intracranial necrotic lesion in the period of 
November 2004 till January 2007. Each patient 
underwent an unenhanced CT scan and a CT perfusion of 
the brain. Ethical clearance was approved by the 
institutional review board and informed consent was 
obtained by each study participant. 
Our consecutive series were selected from patients 
with known intracranial necrotic lesions of either 
cerebral tumour or abscess who were referred to our 
radiology department for CT scan of the brain. There 
were a total of 25 patients who underwent the 
standardised perfusion scan in this study; however 4 
were unsuccessful, with 2 due to severe motion artifacts 
and the other 2 due to technical errors. The successful 
subjects were divided into 2 groups: Group 1, patients 
with brain tumours (n=13), 2 who had glioblastoma 
multiforme, 3 who had primary lymphoma (the diagnosis 
of this group of patients were obtained by biopsy) and 
another 8 who had a known primary carcinoma and 
secondaries to the brain (2 from Ca lung, 2 from 
Ca breast, 1 from Ca stomach, 1 from Ca rectum, 1 from 
Ca cervix and 1 from endometroid Ca). Group 2 were the 
patients with infection, where the diagnosis was achieved 
either by culture of the sample obtained during surgical 
drainage or culture of the cerebrospinal fluid obtained by 
lumbar puncture, (n=8, 2 toxoplasmosis, 
1 staphylococcal infection and 1 streptococcal infection 
from septicaemia, 2 were of mixed culture and 2 were 
undetermined organism given empirical antibiotic 
treatment).  
An unenhanced CT scan of the whole brain was first 
performed using a 16-slice CT scanner (GE LightSpeed 
Plus, Milwaukee) on all patients whereby 2.5mm thick 
transverse sections through the posterior fossa and 5mm 
thick transverse sections through the supratentorial 
region were obtained. The images were then reviewed. 
The intracranial lesion was then identified and a 10mm 
slice which has the most representation of the lesion was 
then selected. Acquisition of CT perfusion data was then 
performed on the region of interest following a bolus 
injection of 40cc of ultravist (iopramide: 370mgI/ml 
strength contrast media) at 4cc per second. All perfusion 
scans were done using the LightSpeed protocol where 
repeated scanning of four adjacent 5mm transverse 
sections was performed with a 45 second cine with 
1 second interval, acquired at 80kvp using 200mAs. A 
25cm field of view was used for all scanning. Data were 
then retro reconstructed into 10mm at 0.5sec interval 
with a matrix of 512 x 512 pixels. 
All the scans were then transferred to the imaging 
workstation (AW4.0; Advantage Windows; GE Medical 
Figure 1  PS map of the patient with necrotic lesion. 
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Systems, Milwaukee, Wisconsin) and analysed using the 
CT perfusion software by GE Medical Systems. The 
colour-coded maps of cerebral perfusion parameters 
were computed when the contrast enhancement curves 
are generated. ROIs in the CT brain images were then 
drawn in the lesion with the greatest enhancement, while 
avoiding the nearby vessels. In the corresponding 
contralateral normal regions, another ROI was also 
generated as a control region (Figure 1). The analysis 
software allowed ROI drawn on the reference image to 
appear simultaneously on all the perfusion maps. This 
procedure is repeated twice for each lesion and the mean 
values were calculated. The size of the ROIs was 
standardised in all the perfusion samples to be within 
115-125mm². 
Relative perfusion of PS was calculated by using the 
results from mirrored regions within the contralateral 
normal hemisphere as reference. (The reason why 
relative value is used instead of absolute values is in the 
Discussion section). 
side   ral contralate   ing correspond    the of   PS   Absolute
lesion    the of    value PS   Absolute
PS   Relative =
 
The parameters of permeability surface (PS: 
ml/100g/min) were evaluated. Statistical analysis was 
performed using SPSS 13.0 Scientific Software Packages 
(Chicago, IL). Standard descriptive statistics, such as 
maximum, minimum, mean ± SD, were calculated. 
Mann-Whitney U test, a nonparametric independent test, 
was used to determine the statistical differences of the 
data obtained. Statistical significance was declared at the 
p< 0.05 level.  
RESULTS 
The Mann-Whitney test revealed that there was no 
significant statistical difference in rCBF (p=0.169), 
rCBV (p=0.192) and rMTT (p=0.385) between necrotic 
brain tumours and cerebral abscess. 
However, there was significant statistical difference 
in rPS value between necrotic brain tumours and cerebral 
abscesses (p=0.005). By applying the ROC curve, a 
value of 25.1 for rPS was found to be the best estimate to 
discriminate cerebral tumours from cerebral abscesses 
with a specificity of 88%, sensitivity of 70% ( Figure 2). 
This means that intracranial necrotic lesion with rPS 
value of more than 25.1, had an 88% chance of being a 
tumour rather than an abscess. 
DISCUSSION 
Intracranial abscesses are life-threatening medical 
emergencies with a mortality rate ranging from 30-70% 
[2, 3]. Delay in proper medical therapy can be 
devastating. At the same time, differentiating intracranial 
abscess from many other disease processes can be 
difficult because of non-specific clinical and 
radiographic findings. The classical ring-enhancing 
appearance of an intracranial abscess can be mimicked 
by several other entities, most notably by a necrotic 
tumour. A report by Erdagon et al [4] concluded that 
diffusion MRI may be sufficient in differentiating 
abscesses from cystic tumours, and that CBV map 
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Figure 2  A box plot graph showing the rPS values in cerebral tumours and cerebral abscesses and the 
discriminant rPS value between these two groups. 
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Table 1  Patients with intracranial necrotic brain neoplasm — Absolute and relative CBF, CBV, MTT and PS 
values 
CBF  CBV  MTT  PS  Pt  Diagnosis 
Absolute  Relative  Absolute  Relative  Absolute  Relative  Absolute  Relative 
1  GBM  29.63 0.33 1.98 0.57 2.59 0.48  31.65  25.52 
2  GBM  22.75 0.50 2.38 1.95 3.42 0.47  12.21  18.78 
3  Ca  Lung  148.59 2.66 9.40 2.65 5.04 1.04  24.76  37.47 
4  Ca  Lung  559.70 3.68  29.26 3.40 3.64  .99  64.82  31.68 
5  Ca  Breast  35.33 1.82 2.99 2.84 7.57 1.42  15.64  72.76 
6  Ca  Breast  78.14 1.26 5.74 1.89 5.22 1.55  21.66  12.95 
7  Ca  Stomach  129.54 2.25 5.50 1.03 7.20 2.07  30.99  31.69 
8  Colorectal  Ca  96.12 1.44 5.37 1.25 6.18 2.07  36.33  49.75 
9  Ca  Cervix  40.09 1.38 2.19 1.47 4.89 1.59 6.11  14.21 
10  Endometroid  Ca  103.83 1.73 5.62 1.34 6.21 1.99  26.33  19.80 
11  lymphoma  20.60 0.71 1.61 0.62 4.69 0.88 3.08  61.60 
12  lymphoma  27.91 0.77 1.96 1.15 3.24  .58 7.35  45.94 
13  lymphoma  35.33 1.82 2.99 1.50 7.57 1.42  15.64  120.31 
 
 
 
 
Table 2  Patients with cerebral infection — absolute and relative values of CBF, CBV, MTT and PS values. 
CBF  CBV  MTT  PS  Pt 
Absolute  Relative  Absolute  Relative  Absolute  Relative  Absolute  Relative 
1  45.06  1.22 2.49  1.58 3.22  1.01 3.32  5.63 
2  56.48  1.92 3.36  2.18 4.64  .82 5.38  20.69 
3  13.46  0.40 0.73  0.39 7.07  1.62 1.05  5.00 
4 112.90  1.84 6.13  1.69 3.95  0.95 4.99  7.45 
5  70.77  1.96 4.96  2.23 5.31  1.08 5.19  24.70 
6 153.23  4.18 6.42  3.22 2.89  .69 7.01  3.81 
7  82.61  2.45 7.05  3.36 5.53  1.17 7.39  26.40 
8 135.00  2.95 6.81  2.46 3.41  .79 4.14  11.19 
 
 
 
 
Table 3  Comparison of perfusion values using between necrotic tumours and abscess. 
  rCBF  rCBV  rMTT  rPS 
  Tumour  Abscess  Tumour  Abscess  Tumour  Abscess  Tumour  Abscess 
N  13 8  13  8  13 8  13 8 
Mean  1.57 2.12  1.66  2.14 1.27 1.02  41.7 13.1 
Median  1.44 1.94  1.47  2.21 1.42 0.980  31.6  9.32 
Std. Deviation  0.934 1.13  0.856  0.952 0.581 0.291  29.8  9.35 
Minimum  0.33 0.40  0.57  0.39 0.47 0.69  13.0  3.81 
Maximum  3.68 4.18  3.40  3.36 2.07 1.62  120  26.4 
p-value  0.169 0.192 0.385 0.005 
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images may aid in differentiation by demonstrating 
lesion vascularity. It was found that the vascular portions 
of abscesses have a decreased rCBV while the peripheral 
portions of malignant cystic tumours had higher 
vascularisation and higher rCBV. 
There were studies describing perfusion parameters, 
mainly CBF and CBV, in the pathologic evolution of 
brain abscesses. Soon after inoculation with an offending 
organism, increases in CBF and CBV were observed. 
These changes were seen 24 hours after innoculation, 
and increased to a maximum between 48-72 hours later, 
at which point perfusion changes appeared to plateau 
within the region of infection. Increased blood brain 
barrier permeability in the infected region was rapidly 
manifested as both regional oedema and minimal ill-
defined areas of contrast-enhancement. The peak 
increase in BBB permeability correlated with the 
appearance of an enhancing ring surrounding the region 
of cerebritis. The most peripheral part of the ring was 
enhanced first, with the more central portion enhancing 
later, occasionally completely filling in the abscess. Thus, 
during the phase of cerebritis, perfusion changes were 
relatively non-specific, and could be mimicked by viral 
encephalitis, lymphoma or primary tumours [5].  
In the early stage of abscess formation, the collagen 
capsule is incomplete, but the perilesional oedema would 
become less extensive. As the vascular proliferation 
becomes maximal, interestingly, it does not extend 
beyond 1 mm of the inflammatory region in the necrotic 
centre. This may not be apparent on conventional CT as 
the ring of contrast enhancement appears thick. With 
dynamic-acquisition, increased rCBV may be present in 
a very thin rim surrounding the necrotic centre; however, 
within the wider area of the abscess wall, decreased 
rCBV is observed [6, 7]. This in contrast with the pattern 
seen in ring-enhancing lesions such as glioblastoma and 
lymphoma, where more angiogenesis at the tumour 
margin is observed and manifested by increased rCBV. 
A study depicted by Ernst et al had used perfusion 
images in distinguishing acquired immunodeficiency 
syndrome (AIDS) lymphoma from toxoplasmosis [8]. 
This distinction frequently cannot be made routinely by 
conventional MR or CT imaging alone. CBV was found 
to be decreased in each of the toxoplasmosis lesions, 
whereas all the active lymphomas displayed regions of 
increased CBV. 
Malignant lesion has been shown to have a high 
permeability to macromolecules due to the presence of 
large gaps between or fenestration of endothelial cell, 
incomplete basement membrane and high vascular 
tortuosity [9]. The high vascular permeability associated 
with high grade gliomas support the fact that these 
neoplasms interrupt the bloodbrain barrier ([10-13]. 
There have been multiple studies looking at MR 
perfusion values in tumour grading; in particular 
demonstrating that higher CBV value is associated with 
higher grade [14, 15] tumours. However MR usage has 
its drawbacks, especially in very ill or debilitated patients. 
With recent advances in multi-slice CT technology 
and friendly commercial software, it is now possible to 
perform perfusion studies on intracranial lesions. Recent 
studies looking at the use of CT perfusion index such as 
CBV and PS found that these parameters provide useful 
information for grading gliomas and might have the 
potential to significantly impact clinical management and 
follow-up of cerebral gliomas. In these studies, 
permeability surface area product has been shown to be 
particularly helpful ([16-18]. There have been studies 
that demonstrated increased conspicuity of tumours 
when using PS index compared to CBV and CBF [19,20]. 
In this study, the permeability maps were also more 
visually conspicuous than the CBF and CBV maps in 
showing up the intracranial tumours. Comparing the PS 
in tumours to that in normal tissue, this study showed 
that tumours yielded an average value that was 30 times 
greater. This study concentrated on differentiation of 
single space occupying lesions, and did not look into the 
grading of gliomas. However, it was found that the CBV 
value was not helpful in the differentiation of primary 
tumour from metastases. 
One of the limitations of CT perfusion is high 
radiation exposure. Even when popular low-dose 
protocols are used, (80 kVp, 200mA, 1s per rotation and 
50 rotations) the volume CT dose index (CTDIvol) is 
estimated to be 500-700mGy with effective dose of 2.8 
to 7.8 mSv. This value is approximately 10 times higher 
than the diagnostic reference level of the brain CT and is 
roughly equal to that of cerebral angiography. Currently, 
80kVp is widely accepted as an appropriate tube voltage 
because the radiation exposure can be reduced to one-
third of that with 120kVp and the contrast between 
iodine contrast agents and brain tissues can be enhanced 
[21,22]. Tube current of 200mA is also optimal as 
excessive reduction would induce increase in quantum 
noise from X-ray photons, resulting in serious errors in 
analysis. Scanning with slow rotation speed up to 1.5s 
can reduce tube current to two-thirds while maintaining 
the signal-to-noise ratio. The intermittent scanning at 
every second can also reduce the dose by 50%. In a 
report by M. Sasaki et al., a CTDI vol of approximately 
100-170mGy can be achieved by utilising an ultra low-
dose protocol (80kVp, 30-50mA, 1.5s/rotation and 
30 rotations) and a sophisticated filter, which selectively 
removes quantum noises while preserving image details 
[23]. 
The other limitations and controversies are the 
current use of low-molecular weight contrast for human 
subjects. It is hypothesised that contrast agents with low 
molecular weights may leak relatively easily from blood 
into the interstitial and therefore lead to overestimation 
of permeability [24]. Alternatively, contrast agents with 
high molecular weights leak blood more slowly, and 
transfer into interstitial matrix is limited in relation to 
tumour blood flow. It is postulated that the use of low 
molecular weight contrast in this study 
(Iopromide=791.12) may affect the permeability index 
on the normal contra-lateral side, which should be 
negligible. In the absence of a nanoparticulate
 contrast 
agents which is synthesised to a precise size to allow a 
more accurate
  and independent monitoring of tumor 
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vessel permeability and vascular
 volume as suggested by 
Choyke [25], it was proposed to normalise the PS by 
using relative PS measurements. In this study, this 
method has been proven to provide statistical significant 
results to differentiate abscess from necrotic tumours. 
The other disadvantage is the narrow scanning range 
and therefore narrow anatomic coverage, which is 
restricted to 20-40mm even in novel multi-detector row 
CT . Combined with faster tube rotation speeds, table-
toggling techniques, or increased detector elements 
perfusion, CT studies covering the whole brain may 
become possible [26,27]. 
Further studies are needed to better establish the 
precise sensitivity and specificity of CT perfusion 
imaging in relation to the time course of the perfusion 
parameters changes following the onset of cerebral 
abscess. The low number of cases in this study may be a 
limitation. Further studies with larger numbers, including 
more variety of tumours and abscesses at various stages, 
should be conducted. 
CONCLUSION 
To the best of the authors' knowledge, this is the 
first study in which the correlation between PS in 
differentiation of intracranial tumours and abscess was 
investigated. Overall there was a much higher value in 
PS for tumours compared to abscess. In clinical practice, 
when MR cannot be done for various reasons, CTP is a 
fast, easy and widely available alternative for 
differentiation of tumours and abscess. In particular, the 
rPS value above 25.1 would favour the diagnosis of 
cerebral tumours rather than intracranial infection.  
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